Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?
Investors choosing between VanEck Pharmaceutical ETF (PPH +1.11%) and iShares Biotechnology ETF (IBB -0.44%) are weighing a concentrated, dividend-paying basket of drugmakers against a broader, more volatile portfolio of biotech innovators. The…
Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?
State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) and iShares Biotechnology ETF (IBB -0.44%) both offer targeted healthcare exposure, but they differ significantly in sub-sector focus, asset size, and cost structure. Healthcare investors often…
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Rated 'Moderate Buy' by Wall Street Brokerages
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the nine analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Has Consensus Price Target of $313.52
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has received an average recommendation of 'Moderate Buy' from the twenty-one analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a…
Telangana government urged to clear fee reimbursement dues of pharmacy colleges
The Telangana Pharmacy Colleges Managements Association, comprising 120 private colleges and 3 government colleges, with approximately 70,000 students, has urged the government to clear the fee reimbursement dues that are meagre compared to others.
Better Healthcare ETF: Invesco's PJP vs. Simplify's PINK
Comparing the Simplify Health Care ETF (PINK +0.13%) and Invesco Pharmaceuticals ETF (PJP +0.41%) reveals distinct approaches to healthcare, with PINK focusing on broad innovation through active management and PJP offering concentrated exposure to…
Parents whose sons died from kratom use warn about the substance finding allies in Washington
Kratom, a substance that acts on opioid receptors, can be as easy to obtain as a bag of chips. Kratom is derived from a tree native to Southeast Asia, where for generations people have chewed the leaves or boiled them to make a stimulating tea with…
Kura Oncology: JNJ's Bleximenib Is A Serious Threat, But Kura Still Has A Fighting Chance
Kura Oncology is a cautious Hold: my $6.75 valuation implies roughly 10% downside, balanced against an established market presence and combination potential. JNJ's bleximenib showed stronger remission and response-duration metrics, complicating…
60 Minutes Transcript: Kratom, often sold as an herbal supplement, can pose serious health risks
Over the next two weeks, we bring you a special report on the status of the American opioid crisis that's claimed nearly a million casualties and is far from over. We start with kratom. You've probably seen the signs advertising kratom, a substance…
Reuters NEXT New York 2026: Dates, Speakers, Lineup
Reuters has unveiled the speaker lineup for its annual Reuters NEXT leadership summit, set to return to New York for two days starting December 1, 2026. The invitation-only gathering is expected to bring together 600+ CEOs and global decision…
Which Healthcare ETF Is Best for the Long Term: State Street's XPH or Invesco's PBE?
The State Street SPDR S&P Pharmaceuticals ETF (XPH -0.28%) offers broader exposure and lower expenses, while the Invesco Biotechnology & Genome ETF (PBE -0.56%) provides a concentrated, higher-yielding strategy focused on biotech momentum.
Best Growth Stocks To Add to Your Watchlist - November 15th
Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies…
Teva Pharmaceutical Industries Ltd. $TEVA Stock Purchased by Migdal Insurance & Financial Holdings Ltd.
Migdal Insurance & Financial Holdings Ltd. increased its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 1.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The…
From pills to orbit: Boryung heir's bold space bet
Third-generation CEO Kim Jung-gyun targets space revenue by 2030 as he seeks to turn ambitious investments into a viable business When Boryung signed a research cooperation agreement with German aerospace agency DLR last month, the Korean drugmaker…
More MNCs choose Singapore for HQ, but outsized workforce no longer a given
SINGAPORE – More multinational corporations (MNCs) are anchoring their global or regional headquarters in the Republic, but the move no longer entails having a larger workforce here as compared with other markets. The number of foreign HQs…
Receive a Daily briefing on Pharma Industry News
Get Started